Max Robotics — Global Service Robot Directory + US Certification

About

Demetra Fuligni is a rising surgical researcher whose work is reshaping the treatment landscape for prostate cancer and pelvic disorders. Her primary focus lies in the intersection of urologic oncology and advanced surgical techniques, particularly the refinement of focal therapy and robotic-assisted radical prostatectomy (RARP). In two landmark 2023 systematic reviews, Fuligni provided the first comprehensive definitions of cancer control in focal therapy (40 citations) and established a rigorous framework for evaluating functional outcomes and patient-reported outcome measures (38 citations), directly addressing the critical gap between oncological efficacy and quality of life. Her most forward-looking contribution is a 2024 scoping review on artificial intelligence in RARP (15 citations), which maps how machine learning can enhance surgical precision and decision-making for men with localized prostate cancer. Beyond oncology, Fuligni has advanced the understanding of pudendal nerve entrapment through a systematic review of neurolysis techniques (8 citations), and she has pioneered the simultaneous repair of inguinal hernia during RARP using monofilament polypropylene mesh (6 citations), demonstrating a practical, patient-centered approach to multi-procedure surgery. Her work on endoscopic combined intrarenal surgery (6 citations) further showcases her versatility in minimally invasive urology. With over 110 citations across her key papers, Fuligni is establishing herself as a methodical, impactful voice in evidence-based urologic surgery.